Graft Polymer (UK) PLC Pivotal Agreement within European Consortium (0519P)
09 Octubre 2023 - 1:00AM
UK Regulatory
TIDMGPL
RNS Number : 0519P
Graft Polymer (UK) PLC
09 October 2023
This announcement contains inside information for the purposes
of Article 7 of EU Regulation No. 596/2014, which forms part of
United Kingdom domestic law by virtue of the European Union
(Withdrawal) Act 2018 (as amended).
9 October 2023
Graft Polymer (UK) PLC
Consolidating innovative leadership and contract momentum, Graft
Polymer announces pivotal agreement within European consortium for
the University of Belgrade to explore scope for addressing
electromagnetic wave pollution, with potential economic impact for
the electronics industry
Graft Polymer, (LSE:GPL) the multi-sector specialist chemical
company offering modified and alloyed polymer and bio-polymer
solutions for refiners, compounders and processors, is pleased to
announce an agreement as part of the French, German and Slovenian
consortium being coordinated by Vinca Institute of Nuclear Sciences
at the National Institute of the Republic of Serbia within the
University of Belgrade. This relates to the GrinShield Project
Twinning programme for new graphene based composites in
electromagnetic interference shielding (Gr. Num. 101079151, HORIZON
CSA) .
Intense growth in both the telecommunication and electronics
industries in recent years has made the use of electronic devices
part of everyday life, making pollution caused by Electromagnetic
Waves (EWs) emitted from mobile phones, WiFi and microwave ovens
ubiquitous. EM radiation has been known to interact with medical
devices and interference with other electronic devices is well
established and understood, and there is widespread concern on
potential impacts on human health. There is resultant high demand
for textiles which can absorb EWs and the GrinShield project,
exploring the scope for new nanomaterials to act as a protective
barrier, is a key example of new innovation in the development of
EW shielding materials.
Graft Polymer will leverage its proprietary production of
GRAFTALLOY(R) MP-UHMWPE (ultra high molecular weight polyethylene)
and apply its unique NANO graphene emulsion GRAFTASYNT(R) G-NE
& GRAFTASYNT(R) D-Graphene to the resultant alloy. The Company
will then prepare samples for testing by the Institute and agree on
testing procedures ahead of a joint R&D report being produced.
The project is due to last until autumn 2025.
This opportunity builds on Graft Polymer's progress with these
cutting edge products, testament to its innovative leadership in
the polymers market. It is almost impossible to melt Ultra High
Molecular Weight Polyethylene owing to its high melt viscosity,
giving it advantageous characteristics including strong impact,
abrasion, chemical and radiation resistance. Graphene also has
remarkable properties, most notably its electrical conductivity,
thermal stability, impermeability and exceptional mechanical
resistance which make it the most promising nanotechnological
additive in the plastics industry. The outcome of this project has
potential to have a significant economic impact on the electronics
industry.
This agreement comes at a time when the Company has dynamic
commercial momentum with contract, manufacturing, supply,
distribution and R&D agreement signings, and is further
evidence of strong relationships with key R&D institutions. It
also leverages Graft Polymer's expanded Slovenian facility which is
crucial in providing reliable supply capacity and meeting customer
requirements.
Commenting on the agreement, Graft Polymer Founder and Managing
Director Victor Bolduev said: "This agreement is further
acknowledgement of our compelling product innovation and R&D
capabilities, and our success in forging joint development
programmes through customer mandates at the forefront of polymer
evolution in new markets".
On behalf of the Vinca Institute, Professor Snezana Pajovic
commented: "Graft Polymer's proposition and competitive advantage
in innovating and manufacturing unique products in the polymers
market are truly impressive and we look forward to working with
them on this pivotal project".
ENDS
For further information, visit www.graftpolymer.com , follow on
Twitter @PolymerLtd or contact:
Graft Polymer (UK) Plc
Roby Zomer, Non Executive Chairman Via Flagstaff
Yifat Steur, Finance Director
Turner Pope Investments Tel:+44 (0) 20 3657 0050
James Pope
Andy Thacker
Flagstaff Strategic and Investor Communications Tel + 44 (0) 207 129 1474
Tim Thompson graftpolymer@flagstaffcomms.com
Mark Edwards
Alison Allfrey
Anna Probert
About Graft Polymer
Graft Polymer is a London Stock Exchange listed company (GPL)
with a cutting-edge, research and development (R&D) and
manufacturing facility based in Slovenia which has already
introduced more than 50 products to the market. The core business
of the Group comprises polymer modification and drug delivery
system developments. The Group has developed a proprietary set of
polymer modification technologies, including using recycled raw
materials and a closed loop system to reduce waste. Graft Polymer's
technology can improve existing products and processing
methodologies by enhancing performance, simplifying manufacturing,
reducing material consumption, widening the choice of feedstocks,
and reducing costs.
Graft Polymer has three divisions: the first division focusses
on polymer modification; the second is GraftBio which develops IP
for Bio/Pharma applications (including a drug delivery system to
support and provide solutions to the market, which had been heavily
impacted by the COVID-19 pandemic); and the third is the Group's
food supplement division. A significant milestone was reached in
May 2022 when the Slovenian manufacturing facility was granted a
Hazard Analysis and Critical Control Point (HACCP) Certificate. The
HACCP Certificate allows it to enter the lucrative
Business-to-Consumer market and commercialise its IP for bio/pharma
applications, developing active pharmaceutical ingredients and drug
delivery platforms for use in the food supplement market, thereby
introducing a further revenue stream to its business.
Environment, Social and Governance is at the forefront of the
Group's strategy and the facility in Slovenia has been granted ISO
14001 accreditation in recognition of the environmental management
systems in place to reduce waste. Graft Polymer only uses REACH and
ROHS certificated raw materials instead of toxic raw materials, and
its extensive R&D programme has also developed specialised
recycling polymer additives which increases the strength of
recycled blends and plastic products whilst also reducing plastic
waste by between 40 and 50 per cent.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
AGRNKFBDCBDDOKK
(END) Dow Jones Newswires
October 09, 2023 02:00 ET (06:00 GMT)
Graft Polymer (uk) (LSE:GPL)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Graft Polymer (uk) (LSE:GPL)
Gráfica de Acción Histórica
De May 2023 a May 2024